Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
Date:2/28/2013

host)

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About Nektar
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.  Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which is being evaluated in Phase 3 clinical studies as a once- daily, oral tablet for the treatment of opioid-induced constipation.  This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid.  NKTR-181, a novel mu-opioid analgesic candidate for chronic pain conditions, is in Phase 2 development in osteoarthritis patients with chronic knee pain.  NKTR-192, a novel mu-opioid analgesic in development to treat acute pain is in Phase 1 clinical development.  In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatment of metastatic breast cancer and is also in Phase 2 studies for the treatment of ovarian and colorectal cancers.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.  Additional development-stage products that leverage Nektar's proprietary technology platform inc
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Z-Medica, a leading developer ... launched the first-ever line of products designed to meet ... includes QuikClot ® EMS 4x4 Dressing, QuikClot ® ... EMS Rolled Gauze™, all custom-designed to help responders stop ... be transported to a hospital or trauma center. The ...
(Date:5/22/2013)... 22, 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) ... about some recent company developments. As Medifirst continues to ... communication with shareholders. Integrating social media into its investor ... and will post updates on Twitter.  The Facebook homepage ... Says CEO Bruce J. ...
(Date:5/22/2013)... 22, 2013  Flagship Ventures, a leading venture ... and sustainability, today announced the appointment of ... Partner. In this role, Mr. Bancel will provide ... In addition to working closely with companies ... as President and Chief Executive Officer of Moderna ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... Clinic Service Corporation (CSC), the leader in Colorado ... an agreement to be the exclusive provider of medical ... "We are thrilled to add this practice or our ... and Metabolism is an endocrinology leader and pioneer. He ...
... Oct. 1 In a continued effort to keep ... Cross, State Sponsored Business launched an innovative on-line Body ... wheel and web-based interactive practice sessions to help provide ... online BMI training program builds on Anthem,s efforts which ...
Cached Medicine Technology:Anthem Blue Cross Takes BMI Training Virtual with New Online Capability 2Anthem Blue Cross Takes BMI Training Virtual with New Online Capability 3
(Date:5/22/2013)... May 22, 2013 A new study published ... found that of young people who visited fast food or ... who were obese were more likely to use calorie information ... also found that young people eating at fast food or ... likely to use calorie information as those eating there once ...
(Date:5/22/2013)... Nearly 50,000 veterans appeals were received by the ... with even more—54,033—expected by fiscal year-end 2013. However, veterans ... the agency reports reduced decisions and a reduced workforce, ... services. The BVA is an agency of the ... received 49,611 cases in FY 2012, it reached decisions ...
(Date:5/22/2013)... People in the United States have been taking water ... much of the world, water shortages are normal and baths ... warns against taking water for granted and provides ways to ... in the United States. , Sharon Kleyne is host of ... live or by podcast on World Talk Radio, Voice America, ...
(Date:5/22/2013)... Angeles, California (PRWEB) May 22, 2013 According ... article entitled “Women Have More Options for Breast Cancer Surgery,” ... an opportunity to approach this disease in a whole ... has been developed, women now face breast cancer and ... (Go to goo.gl/ARqoN). , “Before the introduction of plastic surgery ...
(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...
Breaking Medicine News(10 mins):Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3
... 24 There is clear evidence,that small amounts ... U.S. water,supplies, present potential risks to the thyroid ... published review of the,fluoride/thyroid literature.(A) Fluoride, in ... U.S.,public water supplies, ostensibly to reduce tooth decay, ...
... stroke starting experiencing sounds as bodily sensations , , MONDAY, ... who experienced sounds as bodily sensations after suffering a ... how the brain processes sensory signals and fixes itself ... to sound after suffering a stroke that only affected ...
... world,s first commercial adopter of vaccine -, ... Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, ... in cattle has been used for the first ... an Ontario-based producer of premium beef,integrated use of ...
... 24 Designed to fill gaps in,existing insurance coverage ... major,health insurance, critical illness coverage offers a lump-sum benefit ... This payment can be,used for any aspect of the ... the,illness you were diagnosed with, says Frank N. Darras, ...
... Coast Pharmacy Grand Opening on October 2, NEWPORT BEACH, ... is hosting a grand opening celebration from 2 p.m.,to 7 ... across from the,prominent Fashion Island Shopping Center. To welcome ... the grand opening activities will include: * FREE ...
... (VL) of the thalamus is connected to the cerebellum ... in motor function. A new study to be published ... American Neurological Association, found that the VL also plays ... this area leads to functional and neural changes. The ...
Cached Medicine News:Health News:Fluoride Damages the Thyroid, Report Shows 2Health News:Study Offers Insights Into Sensory Perceptions 2Health News:Beef Cattle Vaccinated Against E. coli O157:H7 2Health News:Beef Cattle Vaccinated Against E. coli O157:H7 3Health News:Critical Illness Insurance: What You Need to Know 2Health News:New Pharmacy's Owners Go Beyond Your Prescription 2Health News:Area deep within the brain found to play role in sensory perception 2Health News:Area deep within the brain found to play role in sensory perception 3
... Shoulder Holder is used for positioning the ... position. The shoulder holder is adjustable with ... arm positions and sizes. The MITT allows ... arm in the shoulder holder during surgery. ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... No-Profile Screw and Washer is ... multiple soft tissue re-attachments in ... Screw and washer provides the ... standard screw and washer but ...
Medicine Products: